Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov 20;7(22):e010996.
doi: 10.1161/JAHA.118.010996.

Using Ticagrelor to Prevent Recurrent Type 1 and Type 2 Myocardial Infarctions: Boon or Bane?

John A Bittl  1
Affiliations
Editorial

Using Ticagrelor to Prevent Recurrent Type 1 and Type 2 Myocardial Infarctions: Boon or Bane?

John A Bittl. J Am Heart Assoc. .

Abstract

See Editorial by Bonaca et al.

Keywords: Editorials; P2Y12; demand myocardial infarction; dual antiplatelet therapy; myocardial oxygen demand; percutaneous coronary intervention.

PubMed Disclaimer

Comment on

  • Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
    Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt DL, Storey RF, Cohen M, Kuder J, Im K, Magnani G, Budaj A, Nicolau JC, Parkhomenko A, López-Sendón J, Dellborg M, Diaz R, Van de Werf F, Corbalán R, Goudev A, Jensen EC, Johanson P, Braunwald E, Sabatine MS. Bonaca MP, et al. J Am Heart Assoc. 2018 Nov 20;7(22):e009260. doi: 10.1161/JAHA.118.009260. J Am Heart Assoc. 2018. PMID: 30571502 Free PMC article. Clinical Trial.

References

    1. Benjamin EJ, Blaha MJ, Chiuve SE, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Panday DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH‐Y, Alger HM, Wong SS, Muntner P; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–e603. - PMC - PubMed
    1. Bonaca MP, Sabatine MS, Morrow DA. Antiplatelet therapy after myocardial infarction In: Morrow DA, ed. Myocardial Infarction: A Companion to Braunwald's Heart Disease. St Louis, MO: Elsevier; 2017:434–448.
    1. Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; for the PEGASUS‐TIMI 54 Steering Committee and Investigators . Long‐term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015;372:1791–1800. - PubMed
    1. Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt D, Storey R, Cohen M, Kuder J, Im KA, Magnani G, Budaj A, Theroux P, Nicolau J, Parkhomenko A, Lopez‐Sendon JL, Dellborg M, Diaz F, Goudev A, Jensen E, Johanson P, Braunwald E, Sabatine MS. Reduction in subtypes and sizes of myocardial infarction with ticregrelor in PEGASUS‐TIMI 54. J Am Heart Assoc. 2018;7:e009260 DOI: 10.1161/JAHA.118.009260. - DOI - PMC - PubMed
    1. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli‐Ducci C, Katus HA, Pinto FJ, Antman EM, Hamm CW, De Caterina R, Januzzi JL Jr, Apple FS, Garcia MAA, Underwood SR, Canty JM Jr, Lyon AR, Devereaux PJ, Zamorano JL, Lindahl B, Weintraub WS. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72:2231–2264. - PubMed